Clinical Trial Update: Japan-Working Groups of Acute Myocardial Infarction for the Reduction of Necrotic Damage by a K-ATP [NA]

View source ↗

Summary

A completed clinical trial update from Japan assessing reduction of necrotic damage in acute myocardial infarction with a K-ATP channel opener (nicorandil).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Nicorandil (nicorandil)

Snippet

Sponsor: National Cerebral and Cardiovascular Center, Japan | Conditions: Acute Myocardial Infarction | NA | Status: COMPLETED